Bayesian Capital Management’s AMN Healthcare AMN Stock Holding History

Bayesian Capital Management’s Portfolio AMN Stock Details AMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-8,900	Closed	-$218K	–	532
2025 Q1	$218K	Buy	+8,900	New	+$229K	0.04%	473
2022 Q4	–	Sell	-7,942	Closed	-$842K	–	762
2022 Q3	$842K	Buy	7,942 +1,811	+30%	+$199K	0.17%	166
2022 Q2	$673K	Buy	+6,131	New	+$607K	0.13%	248
2020 Q3	–	Sell	-14,996	Closed	-$678K	–	507
2020 Q2	$678K	Buy	14,996 +4,400	+42%	+$210K	0.15%	196
2020 Q1	$613K	Buy	+10,596	New	+$725K	0.13%	237
2019 Q4	–	Sell	-4,766	Closed	-$274K	–	587
2019 Q3	$274K	Buy	+4,766	New	+$264K	0.05%	384
2016 Q4	–	Sell	-10,235	Closed	-$326K	–	587
2016 Q3	$326K	Buy	+10,235	New	+$389K	0.21%	173
2016 Q2	–	Sell	-7,600	Closed	-$255K	–	393
2016 Q1	$255K	Sell	7,600 -2,300	-23%	-$65.8K	0.24%	205
2015 Q4	$307K	Buy	+9,900	New	+$293K	0.44%	94

Other funds holding AMN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bayesian Capital Management's AMN Position: Q2 2025 in Review

Bayesian Capital Management sold out of AMN Healthcare (AMN) in Q2 2025, closing a stake of 8,900 shares — an estimated $218K sold.

Bayesian Capital Management first reported a position in AMN in Q4 2015 and held it in 9 quarters. The position peaked at $842K in Q3 2022. 248 funds tracked by Wall St. Rank hold AMN as of Q2 2025.

Bayesian Capital Management reported no remaining AMN Healthcare position as of Q2 2025 after selling out during the quarter.
Bayesian Capital Management sold 8,900 AMN Healthcare shares in Q2 2025, an estimated $218K.
Bayesian Capital Management first reported a position in AMN Healthcare in Q4 2015 and held it in 9 quarters.
Bayesian Capital Management's AMN Healthcare position peaked at $842K in Q3 2022.
248 funds tracked by Wall St. Rank held AMN Healthcare as of Q2 2025.

Based on Bayesian Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.